ASX Announcements


 
    Appendix 3B  
 
    Final Directors Interest Notice  
 
    2019 AGM CEO Presentation  
 
    2019 AGM Chairmans address  
 
    Updated investor presentation May 2019  
 
    EXL granted New York State CBD Authorization  
 
    Investor Presentation May 2019  
 
    Waiver from Listing Rule 14.7  
 
    Cleansing Statement  
 
    Appendix 3B  
 
    Independent Valuation Report  
 
    Elixinol acquires 25% of US based Pet Releaf  
 
    Quarterly Report and Appendix 4C  
 
    Notice of Annual General Meeting/Proxy Form  
 
    Executive team expanded and Board change  
 
    Initial Director's Interest Notice - Greg Ellery  
 
    Appointment of Greg Ellery  
 
    Corporate Governance Statement and Appendix 4G  
 
    Annual Report  
 
    Investor Update March/April 2019  
 
    2019 Annual General Meeting  
 
    Full Year Results Presentation Conference Call Recording  
 
    FY 2018 Investor Results Presentation  
 
    FY 2018 Results ASX Announcement  
 
    FY 2018 Appendix 4E Preliminary Financial Report  
 
    Elixinol FY2018 Results conference call  
 
    Nunyara land purchase  
 
    EXL expands into Europe driving international growth  
 
    Quarterly Report and Appendix 4C  
 
    Elixinol enters New Zealand market  
 
    CFO relocation and appointment of Joint Company Secretary  
 
    Appendix 3B - Release of Escrowed Securities  
 
    2018 Farm Bill signed by the US President  
 
    EXL Investor Newsletter  
 
    Release of Restricted Securities  
 
    Elixinol Global completes 50.5% investment in Elixinol Japan  
 
    Raw with Life Change of Substantial Holder  
 
    D&G Health Change of Substantial Holder  
 
    EXL Change of Substantial Holder  
 
    Appendix 3B  
 
    EXL Sydney Wholesale Investor Presentation  
 
    Quarterly Report and Appendix 4C  
 
    EXL Aust Microcap Investment Conference Presentation  
 
    Cleansing Statement and Appendix 3B  
 
    Elixinol Global raises A$40m to accelerate international gro  
 
    Trading Halt  
 
    EXL increases ownership in Elixinol Japan  
 
    EXL Commences Trading on OTCQX Market in United States  
 
    EXL Presentation for Investor Briefings September 2018  
 
    1H FY2018 Results Conference Call Recording  
 
    1H 2018 Investor Results Presentation  
 
    1H 2018 Results ASX Announcement  
 
    Appendix 4D and 1H 2018 Interim Report  
 
    Elixinol Global 1H FY2018 results conference call  
 
    Quarterly Report and Appendix 4C  
 
    Historic US Hemp Farming Legislation Passed  
 
    Change of Director's Interest Notice - S Karousos  
 
    Change of Director's Interest Notice - P Benhaim  
 
    Change of Directors Interest Notice - L McLeod  
 
    Change of Directors Interest Notice A Duff  
 
    Appendix 3B  
 
    2017 AGM Results  
 
    2017 AGM Presentation  
 
    2017 AGM Chairmans address  
 
    Quarterly Report and Appendix 4C  
 
    Elixinol enters into Joint Venture  
 
    Notice of Annual General Meeting & Proxy Form  
 
    Appendix 3B  
 
    FY2017 Investor Results Presentation  
 
    FY2017 Results ASX Announcement  
 
    Corporate Governance Statement and Appendix 4G  
 
    Appendix 4E and 2017 Annual Report  
 
    Appendix 4C - quarterly  
 
    Initial Director's Interest Notice - S Karousos  
 
    Initial Director's Interest Notice - L McLeod  
 
    Initial Director's Interest Notice - P Benhaim  
 
    Initial Director's Interest Notice - A Duff  
 
    Substantial Shareholder Notice - DG  
 
    Substantial Shareholder Notice - RWL  
 
    Substantial Shareholder Notice - Elixinol  
 
    EXL begins trading on ASX  
 
    ASX Market Release  
 
    Pre-Quotation Disclosure Notice  
 
    Corporate Governance Statement  
 
    Securities Trading Policy  
 
    Equity Plan Rules  
 
    Hemp Foods Aust Pty Ltd Accounts FY 2015, 2016 and 2017  
 
    Elixinol Pty Ltd Accounts HY 2017  
 
    Elixinol Pty Ltd Accounts FY 2016  
 
    Elixinol LLC Accounts FY 2015, 2016 and HY 2017  
 
    Constitution  
 
    Appendix 1A and Information Form and Checklist  
 
    Top 20 Shareholders  
 
    Distribution Schedule  
 
    Prospectus  
 
    ASX Market Release - Admission to Official List